M. Reck
Impact in
-
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 10
- Cancer Immunotherapy and Biomarkers 5
- Lung Cancer Research Studies 3
-
- Lung Cancer Treatments and Mutations 4
- Pleural and Pulmonary Diseases 1
- Co-authors
- Peter Ellis (1 shared paper)Kenneth John O'Byrne (1 shared paper)Wolfgang Pfeifer (1 shared paper)Rodryg Ramlau (1 shared paper)Assaad Chemaissani (1 shared paper)Robert Pirker (1 shared paper)Korinna Pilz (1 shared paper)Tobias Welte (1 shared paper)
- Journals
- Annals of Oncology (5 papers)Critical Reviews in Oncology/Hematology (1 paper)Journal of Clinical Oncology (1 paper)Journal of Thoracic Oncology (1 paper)Pneumologie (2 papers)
- Partner nations
- GermanyUnited StatesSpain
In The Last Decade
M. Reck
12 papers receiving 297 citations
Peers
Comparison fields: 5 of 25
- Oncology 211
- Pulmonary and Respiratory Medicine 176
- Hepatology 8
- Cancer Research 14
- Epidemiology 28
Countries citing papers authored by M. Reck
This map shows the geographic impact of M. Reck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Reck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Reck more than expected).
Fields of papers citing papers by M. Reck
This network shows the impact of papers produced by M. Reck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Reck. The network helps show where M. Reck may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Reck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 220 | |
| 2 | 2019 | 55 | |
| 3 | 2015 | 19 | |
| 4 | 2017 | 5 | |
| 5 | 2009 | 3 | |
| 6 | Rash as a marker for the efficacy of necitumumab in the SQUIRE Study | 2015 | 3 |
| 7 | 2011 | 2 | |
| 8 | 2006 | 1 | |
| 9 | 進行性NSCLC患者におけるカルボプラチンとパクリタキセルを併用した,TRAIL-R1アゴニスト単クローン抗体マパツムマブの無作為化第2相試験 | 2010 | 1 |
| 10 | 2020 | 1 | |
| 11 | 2008 | 1 | |
| 12 | 2012 | 1 |
About M. Reck
M. Reck is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Immunology and Gastroenterology, having authored 12 papers that have together received 312 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Lung Cancer Treatments and Mutations (4 papers), Lung Cancer Research Studies (3 papers), Cancer Genomics and Diagnostics (2 papers), Immunotherapy and Immune Responses (2 papers), Cancer Research and Treatments (1 paper), Nanoparticle-Based Drug Delivery (1 paper) and Pleural and Pulmonary Diseases (1 paper). The work is most often cited by research in Oncology (211 citations), Pulmonary and Respiratory Medicine (176 citations), Hepatology (8 citations), Cancer Research (14 citations) and Epidemiology (28 citations). M. Reck has collaborated with scholars based in Germany, United States and Spain. Frequent co-authors include Peter Ellis, Kenneth John O'Byrne, Wolfgang Pfeifer, Rodryg Ramlau, Assaad Chemaissani, Robert Pirker, Korinna Pilz, Tobias Welte, Maurice Pérol and Malcolm Ranson. Their work appears in journals such as Annals of Oncology, Critical Reviews in Oncology/Hematology, Journal of Clinical Oncology, Journal of Thoracic Oncology and Pneumologie.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.